A randomized phase III post-operative trial of platinum-based chemotherapy versus capecitabine in patients with residual triple-negative breast cancer (TNBC) following neoadjuvant chemotherapy: ECOG-ACRIN EA1131 - Mayer, IA (ASCO, 2021)